Clinical Trial Update: Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating combination chemotherapy in children with refractory or relapsed Hodgkin lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Snippet

Sponsor: Children's Oncology Group | Conditions: Lymphoma | Phase 2 | Status: COMPLETED